The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer
Authors:
Open Access
- 1 January 2016
- journal article
- research article
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 11 (1) , 59-62
Abstract
Non-small cell lung cancer (NSCLC) is the leading cause of cancer related deaths worldwide. But no one type of serum biomarker was found to be highly sensitive and specific for detection of lung cancer at present. So, the aim of this study was to evaluate a diagnostic value of serum carcinoembryonic antigen (CEA), neuron specific enolase (NSE) and matrix metallo-proteinase (MMP-9) for non-small cell lung cancer. Thirty-six cases with pathology confirmed non-small cell lung cancer and thirty-two of subjects with benign lung disease were reviewed in our hospital and included in this retrospective study. The serum level of CEA, NSE and MMP-9 were tested and compared between the non-small cell lung cancer patients and benign lung disease. The diagnosis sensitivity, specificity and area under the receiver-operating characteristic (ROC) curve (AUC) for serum CEA, NSE and MMP-9 were calculated with STATA10.0 software. The serum CEA, NSE and MMP-9 were 32.0±16.7 ng/mL, 51.6±68.3 ng/mL, 30.6 ±15.7 μg/L for the NSCLC patients and 15.1±10.9 ng/mL, 4.9±3.1 ng/mL, 9.3±5.9 μg/L for the benign lung disease patients with statistical difference (Pall<0.05); The diagnosis sensitivity, specificity and AUC were 80.0%, 72.2%, 0.84 for the serum CEA; 71.0%, 83.3% and 0.80 for NSE and 87.1%, 80.56%, 0.89 for MMP-9, respectively. The serum CEA, NSE and MMP-9 were generally elevated in patients with non-small cell lung cancer and could be used as potential bio-markers for non-small cell lung cancer diagnosis.Keywords
This publication has 15 references indexed in Scilit:
- Serum protein profiles of patients with lung cancer of different histological typesAsia-Pacific Journal of Clinical Oncology, 2015
- Treatment of Elderly Patients With Non–Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyClinical Lung Cancer, 2015
- Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer.2015
- Epidemiology of lung cancer in ChinaThoracic Cancer, 2015
- CA 19-9 As a Marker in Addition to CEA to Monitor Colorectal CancerClinical Colorectal Cancer, 2014
- Prognosis of lung cancer patients in Japan according to data from the Japanese Joint Committee of Lung Cancer RegistryRespiratory Investigation, 2014
- Matrix Metalloproteinase-9 Expression in Lung Cancer Patients and Its Relation to Serum MMP-9 Activity, Pathologic Type, and PrognosisJournal of Bronchology & Interventional Pulmonology, 2014
- Preparing for tomorrow: Molecular diagnostics and the changing nonsmall cell lung cancer landscapeAsia-Pacific Journal of Clinical Oncology, 2014
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012